Impact of Non-Coding RNAs on Chemotherapeutic Resistance in Oral Cancer

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2022 Feb 25

PMID 35204785

Authors

Karen Yamaguchi

Tomofumi Yamamoto

Junichiro Chikuda

Tatsuo Shirota

Yusuke Yamamoto

Affiliations

Soon will be listed here.

Abstract

Drug resistance in oral cancer is one of the major problems in oral cancer therapy because therapeutic failure directly results in tumor recurrence and eventually in metastasis. Accumulating evidence has demonstrated the involvement of non-coding RNAs (ncRNAs), such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), in processes related to the development of drug resistance. A number of studies have shown that ncRNAs modulate gene expression at the transcriptional or translational level and regulate biological processes, such as epithelial-to-mesenchymal transition, apoptosis, DNA repair and drug efflux, which are tightly associated with drug resistance acquisition in many types of cancer. Interestingly, these ncRNAs are commonly detected in extracellular vesicles (EVs) and are known to be delivered into surrounding cells. This intercellular communication via EVs is currently considered to be important for acquired drug resistance. Here, we review the recent advances in the study of drug resistance in oral cancer by mainly focusing on the function of ncRNAs, since an increasing number of studies have suggested that ncRNAs could be therapeutic targets as well as biomarkers for cancer diagnosis.

Citing Articles

Solanine Inhibits Proliferation and Angiogenesis and Induces Apoptosis through Modulation of EGFR Signaling in KB-ChR-8-5 Multidrug-Resistant Oral Cancer Cells.

Prasad P, Jaber M, Awad Alahmadi T, S Almoallim H, Ramu A J Clin Med. 2024; 13(15).

PMID: 39124760 PMC: 11313312. DOI: 10.3390/jcm13154493.

Artificial Intelligence-Driven Multiomics Network Analysis Reveals Resistance Mechanisms in Oral Cancer.

Yadalam P, Ardila C Int Dent J. 2024; 74(5):1180-1181.

PMID: 39097437 PMC: 11561514. DOI: 10.1016/j.identj.2024.07.010.

Potential of melatonin to reverse epigenetic aberrations in oral cancer: new findings.

Gil-Martin E, Ramos E, Lopez-Munoz F, Egea J, Romero A EXCLI J. 2024; 22:1280-1310.

PMID: 38234969 PMC: 10792176. DOI: 10.17179/excli2023-6624.

The Roles of Exosomes in the Diagnose, Development and Therapeutic Resistance of Oral Squamous Cell Carcinoma.

Shi S, Yu Z, Jia J Int J Mol Sci. 2023; 24(3).

PMID: 36768288 PMC: 9916286. DOI: 10.3390/ijms24031968.

Chemotherapeutic Drug Resistance Associated with Differential miRNA Expression of miR-375 and miR-27 among Oral Cancer Cell Lines.

Huni K, Cheung J, Sullivan M, Robison W, Howard K, Kingsley K Int J Mol Sci. 2023; 24(2).

PMID: 36674758 PMC: 9865318. DOI: 10.3390/ijms24021244.

References

Pan L, Chen H, Bai Y, Wang Q, Chen L . Long non-coding RNA CASC2 serves as a ceRNA of microRNA-21 to promote PDCD4 expression in oral squamous cell carcinoma. Onco Targets Ther. 2019; 12:3377-3385. PMC: 6510394. DOI: 10.2147/OTT.S198970. View

Sang Y, Chen B, Song X, Li Y, Liang Y, Han D . circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer. Mol Ther. 2019; 27(9):1638-1652. PMC: 6731174. DOI: 10.1016/j.ymthe.2019.05.011. View

Jia B, Dao J, Han J, Huang Z, Sun X, Zheng X . LINC00958 promotes the proliferation of TSCC via miR-211-5p/CENPK axis and activating the JAK/STAT3 signaling pathway. Cancer Cell Int. 2021; 21(1):147. PMC: 7931557. DOI: 10.1186/s12935-021-01808-z. View

Tang L, Xiong W, Zhang L, Wang D, Wang Y, Wu Y . circSETD3 regulates MAPRE1 through miR-615-5p and miR-1538 sponges to promote migration and invasion in nasopharyngeal carcinoma. Oncogene. 2020; 40(2):307-321. DOI: 10.1038/s41388-020-01531-5. View

Drinberg V, Bitcover R, Rajchenbach W, Peer D . Modulating cancer multidrug resistance by sertraline in combination with a nanomedicine. Cancer Lett. 2014; 354(2):290-8. DOI: 10.1016/j.canlet.2014.08.026. View

Chen L, Yang L . Regulation of circRNA biogenesis. RNA Biol. 2015; 12(4):381-8. PMC: 4615371. DOI: 10.1080/15476286.2015.1020271. View

Ai Y, Song J, Wei H, Tang Z, Li X, Lv X . circ_0001461 promotes oral squamous cell carcinoma progression through miR-145/TLR4/NF-κB axis. Biochem Biophys Res Commun. 2021; 566:108-114. DOI: 10.1016/j.bbrc.2021.06.009. View

Vincent T, Neve E, Johnson J, Kukalev A, Rojo F, Albanell J . A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol. 2009; 11(8):943-50. PMC: 3769970. DOI: 10.1038/ncb1905. View

Kulkarni B, Gondaliya P, Kirave P, Rawal R, Jain A, Garg R . Exosome-mediated delivery of miR-30a sensitize cisplatin-resistant variant of oral squamous carcinoma cells via modulating Beclin1 and Bcl2. Oncotarget. 2020; 11(20):1832-1845. PMC: 7244014. DOI: 10.18632/oncotarget.27557. View

10.

Li X, Ren H . Long noncoding RNA PVT1 promotes tumor cell proliferation, invasion, migration and inhibits apoptosis in oral squamous cell carcinoma by regulating miR‑150‑5p/GLUT‑1. Oncol Rep. 2020; 44(4):1524-1538. PMC: 7448409. DOI: 10.3892/or.2020.7706. View

11.

Cui J, Wang H, Zhang X, Sun X, Zhang J, Ma J . Exosomal miR-200c suppresses chemoresistance of docetaxel in tongue squamous cell carcinoma by suppressing TUBB3 and PPP2R1B. Aging (Albany NY). 2020; 12(8):6756-6773. PMC: 7202518. DOI: 10.18632/aging.103036. View

12.

Hou R, Wang L, Wu Y . Predicting ATP-Binding Cassette Transporters Using the Random Forest Method. Front Genet. 2020; 11:156. PMC: 7109328. DOI: 10.3389/fgene.2020.00156. View

13.

Urabe F, Patil K, Ramm G, Ochiya T, Soekmadji C . Extracellular vesicles in the development of organ-specific metastasis. J Extracell Vesicles. 2021; 10(9):e12125. PMC: 8287318. DOI: 10.1002/jev2.12125. View

14.

Dhillon K, Swisher E, Taniguchi T . Secondary mutations of BRCA1/2 and drug resistance. Cancer Sci. 2011; 102(4):663-9. PMC: 3095365. DOI: 10.1111/j.1349-7006.2010.01840.x. View

15.

Das S, Ansel K, Bitzer M, Breakefield X, Charest A, Galas D . The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research. Cell. 2019; 177(2):231-242. PMC: 6601620. DOI: 10.1016/j.cell.2019.03.023. View

16.

Wang F, Ji X, Wang J, Ma X, Yang Y, Zuo J . LncRNA PVT1 Enhances Proliferation and Cisplatin Resistance via Regulating miR-194-5p/HIF1a Axis in Oral Squamous Cell Carcinoma. Onco Targets Ther. 2020; 13:243-252. PMC: 6957095. DOI: 10.2147/OTT.S232405. View

17.

Chang C, Hsu C, Chang C, Tsai L, Chang Y, Lu S . Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer. Oncol Rep. 2011; 26(4):1003-10. DOI: 10.3892/or.2011.1360. View

18.

Liu T, Chen G, Sun D, Lei M, Li Y, Zhou C . Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma. Acta Biochim Biophys Sin (Shanghai). 2017; 49(9):808-816. DOI: 10.1093/abbs/gmx078. View

19.

Zhang S, Ma H, Zhang D, Xie S, Wang W, Li Q . LncRNA KCNQ1OT1 regulates proliferation and cisplatin resistance in tongue cancer via miR-211-5p mediated Ezrin/Fak/Src signaling. Cell Death Dis. 2018; 9(7):742. PMC: 6030066. DOI: 10.1038/s41419-018-0793-5. View

20.

Wang J, Jiang C, Li N, Wang F, Xu Y, Shen Z . The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway. Cell Death Dis. 2020; 11(8):682. PMC: 7443145. DOI: 10.1038/s41419-020-02851-w. View